Skip to content

Assembly Biosciences ASMB Comprehensive Income (Loss), Net of Tax, Attributable to Parent

Comprehensive Income (Loss), Net of Tax, Attributable to Parent at other companies

Avalo Therapeutics logo
Avalo TherapeuticsAVTX
-$19.7M-49.9%
Arbutus Biopharma Corporation logo
Arbutus Biopharma CorporationABUS
$169.6M+791%
Absci Corporation logo
Absci CorporationABSI
-$29.89M-13.5%
AbCellera Biologics Inc. logo
AbCellera Biologics Inc.ABCL
-$41.35M+14.3%
Arrowhead Research logo
Arrowhead ResearchARWR
ALN
Alnylam PharmaceuticalsALNY

Other financials

Income statement

See full
Revenue$8.2M-12.8%
Operating income-$11.4M-14.4%
Net income-$9.1M-3.0%
EPS (diluted)-$0.54+53.8%

Balance sheet

See full
Cash & equivalents$31.1M+32.9%
Total debt$2.5M-17.5%
Total equity$198.6M+632%
Total assets$235.5M+138%

Cash flow

See full
Operating cash flow-$22.1M+5.7%
CapEx$19.0K
Free cash flow-$22.1M+5.6%

Valuation

See full
Market cap$480.77M+262%
Enterprise value$452.14M+302%
P/S6.8×+2.6×

Profitability

See full
Operating margin-116.8%-26.1pp
Net margin-103.6%-22.7pp
FCF margin-150%-231pp

Returns & leverage

See full
Return on equity-36.9%-15.1pp
Debt / equity-0.1×
Current ratio6.6×+4.6×

Where this comes from

Reported directly by Assembly Biosciences in its filing.

Tagged under the XBRL concept us-gaap:ComprehensiveIncomeNetOfTax.

The official record: Assembly Biosciences’s 10-Q, filed May 7, 2026, on SEC EDGAR. View the filing →

Ask your AI about Assembly Biosciences's comprehensive income (loss), net of tax, attributable to parent.

Connect your AI assistant and compare it to peers, right in your chat.

Connect your AI
Harbor at dusk
Claude

Questions, answered.

What is Assembly Biosciences's comprehensive income (loss), net of tax, attributable to parent?
Assembly Biosciences (ASMB) reported comprehensive income (loss), net of tax, attributable to parent of -$9.41M in Q1 2026.
How has Assembly Biosciences's comprehensive income (loss), net of tax, attributable to parent changed year-over-year?
Assembly Biosciences's comprehensive income (loss), net of tax, attributable to parent decreased by 6.2% year-over-year, from -$8.86M to -$9.41M.
What is the long-term trend for Assembly Biosciences's comprehensive income (loss), net of tax, attributable to parent?
Over 3 years (2021 to 2024), Assembly Biosciences's comprehensive income (loss), net of tax, attributable to parent has grown at a -32.3% compound annual growth rate (CAGR), from -$130M to -$40.31M.
What does comprehensive income (loss), net of tax, attributable to parent mean?
This metric measures the total change in equity from non-owner sources, encompassing both net income and other comprehensive income items such as unrealized gains or losses on securities. It provides a comprehensive view of the company's financial performance by including items that bypass the traditional income statement. This figure is essential for assessing the total economic impact of all financial activities on the company's net worth.